DanGer Shock
2024
Microaxial Flow Pump in Infarct-Related Cardiogenic Shock
In 360 patients with STEMI-related cardiogenic shock, a microaxial flow pump (Impella CP) reduced 180-day all-cause mortality compared with standard care.
Result
Efficacy: All-cause mortality at 180 daysHR 0.74
Below 1 favours microaxial flow pump (Impella CP), above 1 favours standard care.
- Absolute difference
- 12.7 points
The absolute difference is derived from the event rates.
Also reported: NNT 8). More severe bleeding, limb ischaemia, haemolysis and renal failure.
- Subtopic
- Cardiogenic shock
- Design
- RCT, 180-day follow-up
- Relevance
- Important: one of several pillars.
- Cited in
- ACC/AHA 2025 ACS
- Source
- Møller JE, et al. N Engl J Med. 2024;390(15):1382-1393.doi 10.1056/NEJMoa2312572
Discussion & critique
First positive mechanical-support RCT in AMI cardiogenic shock, but strict selection (STEMI, no prolonged-resuscitation arrest). ACC/AHA 2024 class IIa. Complications are frequent: patient selection is everything.